The prevalence of fecal colonization of enterococci, the resistance of the isolates to ampicillin, vancomycin, and high-level aminoglycosides, and the clonal relationship among isolates

Microbial Drug Resistance

Volumn 11, Issue 2, 2005, Pages 159-164

  Kuzucu, Cigdem ^a   Cizmeci, Zeynep ^a   Durmaz, Riza ^a   Durmaz, Bengul ^a   Ozerol, Ibrahim Halil ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; GENTAMICIN; STREPTOMYCIN; VANCOMYCIN;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CULTURE MEDIUM; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; GASTROINTESTINAL TRACT; GENETIC VARIABILITY; HOSPITAL PATIENT; HUMAN; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; OUTPATIENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; VANA GENE; VANB GENE;

AMINOGLYCOSIDES; AMPICILLIN RESISTANCE; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FECES; HUMANS; POLYMERASE CHAIN REACTION; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS AVIUM; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 18944394015     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.159     Document Type: Article

References (30)

1. Ayan, M., R. Durmaz, E. Aktas, and B. Durmaz. 2003. Bacteriological, clinical and epidemiological characteristic of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J. Hosp. Infect. 54:39-45.
2. Braak, N., A. Ott, A. Belkum, J.A.J.W. Kluytmans, J.G.M. Koeleman, L. Spanjaard, A. Voss, A.J.L. Weersink, C.M.J.E. Vandenbroucke Grauls, A.G.M. Buiting, H.A. Verbrugh, and H.P. Endtz. 2000. Prevalence and determinants of fecal colonization with vancomycin resistant enterococcus in hospitalized patients in the Netherlands. Infect. Control Hosp. Epidemiol. 21:520-524.
3. Cetinkaya, Y., P. Falk, and C.G. Mayhall. 2000. Vancomycin resistant enterococci. Clin.Microbiol. Rev. 13:686-707.
4. Chow, J.W. 2000. Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31:586-589.
5. Cinar, T., H. Leblebicioglu, M. Sunbul, C. Eroglu, S. Esen, and M. Gunaydin. 1999. Determination of high level gentamicin and streptomycin resistance in enterococci. Flora 4:114-119.
6. Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
7. Durmaz, R., B. Durmaz, M. Bayraktar, I.H. Ozerol, M.T. Kalcioglu, E. Aktas, and Z. Cizmeci. 2003. Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey. J. Clin. Microbiol. 41:5285-5287.
8. Elliot, I.A., K.D. Farmer, and R.R. Facklam. 1998. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulse field gel electrophoresis type. J. Clin. Microbiol. 36:2115-2116.
9. Ersoy, Y., E. Sonmez, H.J. Young, E. Agel, and B. Durmaz. 2001. Investigation of glycopeptide resistance in enterococcal strains isolated from Malatya, Kayseri and Elazig medical Faculty hospitals. Mikrobiol. Bul. 35:197-209.
10. Goossens, H. 1998. Spread of vancomycin resistant enterococci: differences between the United States and Europe. Infect. Control Hosp. Epidemiol. 19:546-551.
11. Harthug, S., G.E. Eide, and N. Langeland. 2000. Nosocomial outbreak of ampicillin resistant Enterococcus faecium: risk factors for infection and fatal outcome. J. Hosp. Infect. 45:135-144.
12. Harthug, S., R. Jureen, S.C. Mohn, A. Digranes, G.S. Simonsen, A. Sundsfjord, N. Langeland, and The Norwegian Enterococcal Study Group. 2002. The prevalence of faecal carriage of ampicillin resistant and high level gentamicin resistant enterococci among inpatients at 10 major Norwegian hospitals. J. Hosp. Infect. 50:145-154.
13. Johnson, A.P., C. Henwood, S. Mushtaq, D. James, M. Warner, D.M. Livermore, and The ICU Study Group. 2003. Susceptibility of gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. J. Hosp. Infect. 54:179-187.
14. Jordens, J.Z., J. Bates, and D.T. Griffiths. 1994. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34:515-528.
15. Jueen, R., J. Top, S.C. Mohn, S. Harthug, N. Langeland, and J.L. Willems. 2003. Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J. Clin. Microbiol. 41:2330-2336.
16. Koneman, E.W., S.D. Allen, W.M. Janda, P.C. Schreckenberger, and W.C. Winn. 1997. Color atlas and text book of diagnostic microbiology. Lippincott, Philadelphia.
17. Landman, D., J.M. Quale, E. Oydna, B. Willey, V. Ditore, M. Zaman, K. Patel, G. Saurina, and W. Huang. 1996. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J. Clin. Microbiol. 34:751-752.
18. Marione, W.J. 1998. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect. Control. Hosp. Epidemiol. 19:539-545.
19. Moaddab, S.R., and K. Toreci. 2000. Species level identification and investigation of resistance to vancomycin and some other antibiotics in enterococcus strains. J. Turkish Microbiol. Soc. 30:77-84.
20. Mundy, L.M., D.F. Sahm, and M. Gilmore. 2000. Relationships between enterococcal virulence and antimicrobial resistance. Clin. Microbiol. Rev. 13:513-522.
21. National Committee for Clinical Laboratory Standards. 2003. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, 8th ed. M2-A8/Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 6th ed. M7-A6. Wayne, PA.
22. Patterson, J.E., and M. Zervos. 1990. High-level gentamicin resistance in enterococcus: microbiology, genetic basis, and epidemiology. Rev. Infect. Dis. 12:644-652.
23. Robert, C., and J.R. Moellering. 2000. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In G.L. Mandell, J.E. Bennett, and R. Dolin (eds.), Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp. 2147-2156.
24. Schmitz, F.J., J. Verhoef, A.C. Fluit, and SENTRY Participants Group. 1999. Prevalence of aminoglycoside resistance in 20 European University hospitals participating in the European SENTRY antimicrobial surveillance programme. Eur. J. Clin. Microbiol. Infect. Dis. 18:414-421.
25. Simonsen, G.S., B.M. Andersen, A. Digranes, S. Harthug, T. Jacobsen, E. Lingaas, O.B. Natas, O. Olsvik, S.H. Ringertz, A. Skulberg, G. Syversen, and A. Sundsfjord. 1998. Low faecal carrier rate of vancomycin-resistant enterococci in Norwegian hospital patients. Scand. J. Infect. Dis. 30:465-468.
26. Spera, R.V., and B.F. Farber. 1994. Multidrug-resistant Enterococcus faecium. Drugs 48:678-688.
27. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
28. Toledano, H., Y. Schlesinger, D. Raveh, B. Rudensky, D. Attias, A.I. Eidelman, and A.M. Yimon. 2000. Prospective surveillance of vancomycin resistant enterococci in a neonatal intensive care unit. Eur. J. Clin. Infect. Dis. 19:282-287.
29. Weinstein, J.W., M. Roe, M. Towns, L. Sanders, J.J. Thorpe, G.R. Corey, and D.J. Sexton. 1996. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect. Control Hosp. Epidemiol. 17:36-41.
30. Welsh, J., and M. McClelland. 1993. Characterization of pathogenic microorganisms by genomic fingerprinting used arbitrarily primed PCR. In D.H. Persing, T.F. Smith, F. Tenover, and T.J. White (eds.), Diagnostic molecular microbiology. Principles and applications. American Society for Microbiology, Washington, DC, pp. 595-602.